GPX4 and acute myeloid leukemia: Previous studies (49,57) have demonstrated that GPX4 is upregulated in AML cells, which enables cells to restrict ferroptosis through reduced lipid peroxide levels, which ultimately increases AML cell survival and drug resistance (58).